EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo


Blood 91(8): 2672-2678
Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo
It is still uncertain whether multilineage hematopoietic progenitor cells are affected by human immunodeficiency virus-1 (HIV-1) infection in vivo. The SCID-hu Thy/Liv model is permissive of long-term multilineage human hematopoiesis, including T lymphopoiesis. This model was used to investigate the effects of HIV-1 infection on early hematopoietic progenitor function. We found that both lineage-restricted and multilineage hematopoietic progenitors were depleted from grafts infected with either a molecular clone or a primary isolate of HIV-1. Depletion of hematopoietic progenitors (including CD34(+) cells, colony-forming units in methylcellulose, and long-term culture-initiating cells) occurred several days before the onset of thymocyte depletion, indicating that the subsequent rapid decline in thymocyte numbers was due at least in part to loss of thymocyte progenitors. HIV-1 proviral genomes were not detected at high frequency in hematopoietic cells earlier than the intrathymic T-progenitor cell stage, despite the depletion of such cells in infected grafts. Proviral genomes were also not detected in colonies derived from progenitor cells from infected grafts. These data demonstrate that HIV-1 infection interrupts both lineage-restricted and multilineage hematopoiesis in vivo and suggest that depletion of early hematopoietic progenitor cells occurs in the absence of direct viral infection.


Accession: 003162932

PMID: 9531575



Related references

Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo. Journal of Virology 72(6): 5121-5127, 1998

Functional reconstitution of thymopoiesis after human immunodeficiency virus infection. Journal of Virology 74(6): 2943-2948, 2000

Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection. Journal of Virology 81(22): 12685-8, 2007

Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus. Journal of Virology 76(5): 2363-2374, 2002

Suppression of in vitro hematopoiesis following human immunodeficiency virus hiv infection. Journal of Cellular Biochemistry Supplement (11 PART D): 51, 1987

Suppression of in vitro hematopoiesis following human immunodeficiency virus infection. Nature (London) 326(6109): 200-203, 1987

Construction and in vivo infection of a new simian/human immunodeficiency virus chimera containing the reverse transcriptase gene and the 3' half of the genomic region of human immunodeficiency virus type 1. Journal of General Virology 84(Pt 7): 1663-1669, 2003

Construction and in vivo infection of a new simian/human immunodeficiency chimeric virus having broader regions derived from human immunodeficiency virus type 1. Journal of Medical Primatology 31(4-5): 274, August, 2002

Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection. Journal of Virology 80(11): 5563-5570, 2006

Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue. Journal of Infectious Diseases 185(10): 1425-1430, 2002